Cortexyme Appoints June Bray to its Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray, a pharmaceutical industry veteran and global drug development and regulatory process expert, to the company...

Related Keywords

June Bray ,David Lamond ,Stacy Roughan ,Cortexyme Inc ,Corporate Communications Investor Relations ,Nasdaq ,Hoechst Roussel Pharmaceuticals ,University Of Rhode Island ,Allergan ,Bayer Healthcare Pharmaceuticals ,Fairleigh Dickinson University ,Regulatory Affairs At Organon ,Berlex Laboratories Inc ,Global Regulatory Affairs ,Cortexyme Board ,Senior Vice President ,Medical Writing ,Vice President ,Regulatory Affairs ,Berlex Laboratories ,Rhode Island ,Pharmaceutical Marketing ,Fairleigh Dickinson ,Corporate Communications ,